Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000896264-25-000126
Filing Date
2025-05-06
Accepted
2025-05-06 14:42:26
Documents
66
Period of Report
2025-03-29

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20250329.htm   iXBRL 10-Q 772156
2 EX-31.1 usna-20250329xex311.htm EX-31.1 10012
3 EX-31.2 usna-20250329xex312.htm EX-31.2 9876
4 EX-32.1 usna-20250329xex321.htm EX-32.1 3480
5 EX-32.2 usna-20250329xex322.htm EX-32.2 3880
  Complete submission text file 0000896264-25-000126.txt   4492744

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20250329.xsd EX-101.SCH 29455
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT usna-20250329_cal.xml EX-101.CAL 53063
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT usna-20250329_def.xml EX-101.DEF 105422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20250329_lab.xml EX-101.LAB 438783
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20250329_pre.xml EX-101.PRE 300109
68 EXTRACTED XBRL INSTANCE DOCUMENT usna-20250329_htm.xml XML 512128
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 25916695
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)